IL238866A0 - Saquinavir nitrate ester for immunomodulation - Google Patents
Saquinavir nitrate ester for immunomodulationInfo
- Publication number
- IL238866A0 IL238866A0 IL238866A IL23886615A IL238866A0 IL 238866 A0 IL238866 A0 IL 238866A0 IL 238866 A IL238866 A IL 238866A IL 23886615 A IL23886615 A IL 23886615A IL 238866 A0 IL238866 A0 IL 238866A0
- Authority
- IL
- Israel
- Prior art keywords
- immunomodulation
- saquinavir
- Prior art date
Links
- 229960005550 OX1001 Drugs 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- SPHXNRBWPVEVAS-UGJKXSETSA-N ox1001 Chemical compound C([C@@H]([C@H](O[N+]([O-])=O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 SPHXNRBWPVEVAS-UGJKXSETSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261728330P | 2012-11-20 | 2012-11-20 | |
| PCT/EP2013/074264 WO2014079868A1 (en) | 2012-11-20 | 2013-11-20 | Saquinavir-no for immunomodulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL238866A0 true IL238866A0 (en) | 2015-06-30 |
Family
ID=49759262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL238866A IL238866A0 (en) | 2012-11-20 | 2015-05-18 | Saquinavir nitrate ester for immunomodulation |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150283127A1 (https=) |
| EP (1) | EP2922545B1 (https=) |
| JP (1) | JP6283680B2 (https=) |
| KR (1) | KR20150084862A (https=) |
| CN (1) | CN104822379B (https=) |
| AU (1) | AU2013349804A1 (https=) |
| BR (1) | BR112015011299A2 (https=) |
| CA (1) | CA2891771A1 (https=) |
| IL (1) | IL238866A0 (https=) |
| MX (1) | MX2015006249A (https=) |
| WO (1) | WO2014079868A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104127858A (zh) * | 2014-07-26 | 2014-11-05 | 滨州医学院 | 甲磺酸沙奎拉韦在制备预防或治疗内毒素血症和脓毒症的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999063816A1 (en) * | 1998-06-09 | 1999-12-16 | Embro William J | Method and composition for the treatment of epidermal irritations and infections |
| FR2779653B1 (fr) * | 1998-06-11 | 2002-12-20 | Inst Nat Sante Rech Med | Utilisation de composes modulateurs du proteasome en therapie |
| WO2003051361A1 (en) * | 2001-12-14 | 2003-06-26 | Cedars-Sinai Medical Center | Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation |
| HRP20140929T1 (hr) * | 2008-08-01 | 2014-12-05 | Onconox Aps | Antitumorska svojstva no-modificiranih inhibitora proteaze |
| WO2012088305A1 (en) * | 2010-12-22 | 2012-06-28 | The Feinstein Institute For Medical Research | Methods for treating systemic lupus erythematosus using hiv protease inhibitors |
-
2013
- 2013-11-20 AU AU2013349804A patent/AU2013349804A1/en not_active Abandoned
- 2013-11-20 KR KR1020157013049A patent/KR20150084862A/ko not_active Withdrawn
- 2013-11-20 EP EP13802901.2A patent/EP2922545B1/en not_active Not-in-force
- 2013-11-20 JP JP2015542309A patent/JP6283680B2/ja not_active Expired - Fee Related
- 2013-11-20 WO PCT/EP2013/074264 patent/WO2014079868A1/en not_active Ceased
- 2013-11-20 CN CN201380060071.4A patent/CN104822379B/zh not_active Expired - Fee Related
- 2013-11-20 CA CA2891771A patent/CA2891771A1/en not_active Abandoned
- 2013-11-20 MX MX2015006249A patent/MX2015006249A/es unknown
- 2013-11-20 BR BR112015011299A patent/BR112015011299A2/pt not_active IP Right Cessation
- 2013-11-20 US US14/443,402 patent/US20150283127A1/en not_active Abandoned
-
2015
- 2015-05-18 IL IL238866A patent/IL238866A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2922545B1 (en) | 2016-09-21 |
| WO2014079868A1 (en) | 2014-05-30 |
| CA2891771A1 (en) | 2014-05-30 |
| EP2922545A1 (en) | 2015-09-30 |
| JP2015537023A (ja) | 2015-12-24 |
| BR112015011299A2 (pt) | 2017-07-11 |
| HK1212895A1 (zh) | 2016-06-24 |
| CN104822379B (zh) | 2017-08-25 |
| JP6283680B2 (ja) | 2018-02-21 |
| AU2013349804A1 (en) | 2015-06-04 |
| KR20150084862A (ko) | 2015-07-22 |
| MX2015006249A (es) | 2015-12-03 |
| US20150283127A1 (en) | 2015-10-08 |
| CN104822379A (zh) | 2015-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3327112T3 (en) | Agse-deficient stamme | |
| GB201403961D0 (en) | No details | |
| GB201304182D0 (en) | No details | |
| GB201400108D0 (en) | No details | |
| GB201411220D0 (en) | No details | |
| GB201313844D0 (en) | No details | |
| GB201403415D0 (en) | No details | |
| IL238866A0 (en) | Saquinavir nitrate ester for immunomodulation | |
| GB201213825D0 (en) | Damper-device for bouncing-device | |
| GB201322955D0 (en) | No details | |
| GB201302155D0 (en) | No details | |
| GB201300109D0 (en) | No details | |
| GB201310646D0 (en) | No details | |
| GB201222705D0 (en) | Scottsaw | |
| GB201220501D0 (en) | Qrds | |
| GB201220309D0 (en) | Gapstep | |
| GB201219637D0 (en) | Prep-able | |
| GB201219536D0 (en) | Jurasic | |
| GB201218706D0 (en) | Corcost-000969494 | |
| GB201218297D0 (en) | MyCatIsFat | |
| GB201218139D0 (en) | Drydam | |
| GB201217934D0 (en) | Standcam | |
| GB201216084D0 (en) | TransVox | |
| GB201215483D0 (en) | Modalyzer | |
| GB201215000D0 (en) | Sel-mache |